Overview

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to provide patients and their physicians with greater understanding of the risks and benefits of commonly used therapies for treatment of non-CF bronchiectasis
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
COPD Foundation
National Jewish Health
Patient-Centered Outcomes Research Institute
University of Alabama at Birmingham
Treatments:
Anti-Infective Agents
Azithromycin
Erythromycin
Criteria
Inclusion Criteria:

- Within Medicare data, indicated diagnosis of Bronchiectasis by a Pulmonologist (ICD-9
code 494.0 and/or 494.1)

Exclusion Criteria:

- cystic fibrosis diagnosis, HIV infection, history of organ transplant